Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jade BiosciencesJBIO -1.78%12 9-Day RSI is 38.30 as of Jul. 30, 2026. GuruFocus rates JBIO with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 1,420 Biotechnology companies, Jade Biosciences ranks better than 56.34% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-30), Jade Biosciences's 9-Day RSI is 38.30.
The industry rank for Jade Biosciences's 9-Day RSI or its related term are showing as below:
JBIO's 9-Day RSI is ranked better than 56.34% of 1420
companies
in the Biotechnology industry
Industry Median: 40.575
vs JBIO: 38.30
Jade Biosciences (NAS:JBIO) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Jade Biosciences 9-Day RSI Related Terms
JBIO vs NVAX, AVLN, TRAX: 9-Day RSI Comparison
For the Biotechnology subindustry, Jade Biosciences's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jade Biosciences 9-Day RSI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jade Biosciences's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Jade Biosciences's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jade Biosciences (JBIO) has a 9-Day RSI of 38.30 as of Jul. 30, 2026. According to the industry distribution chart, Jade Biosciences ranks #620 out of 1420 companies in the Biotechnology industry, placing it in the top 43.7%.
Is Jade Biosciences' 9-Day RSI too high?
Jade Biosciences' current 9-Day RSI is 38.30. The Biotechnology industry median 9-Day RSI is 40.58. Jade Biosciences' value of 38.30 is 5.6% below this industry median. Based on the distribution chart, Jade Biosciences ranks #620 out of 1420 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Jade Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Jade Biosciences' 9-Day RSI compare to NVAX and AVLN?
According to the Biotechnology industry distribution chart, Jade Biosciences ranks #620 out of 1420 companies for 9-Day RSI. This puts Jade Biosciences in the upper half of its industry. The industry median 9-Day RSI is 40.58. Jade Biosciences' value of 38.30 is 5.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Biotechnology company?
The median 9-Day RSI among Biotechnology companies is 40.58, based on 1,420 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jade Biosciences's current 9-Day RSI of 38.30 is 5.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median 9-Day RSI is 40.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jade Biosciences's current 9-Day RSI is 38.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jade Biosciences stock overvalued right now?
Jade Biosciences (JBIO) has a current 9-Day RSI of 38.30. The current 9-Day RSI is 38.30 and 5.6% below the Biotechnology industry median of 40.58. Jade Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Jade Biosciences (JBIO), the current 9-Day RSI is 38.30 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
12GF Score
Get the complete analysis for JBIO
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JBIO has been successfully added to your 
